JP2024534580A5 - - Google Patents
Info
- Publication number
- JP2024534580A5 JP2024534580A5 JP2024518431A JP2024518431A JP2024534580A5 JP 2024534580 A5 JP2024534580 A5 JP 2024534580A5 JP 2024518431 A JP2024518431 A JP 2024518431A JP 2024518431 A JP2024518431 A JP 2024518431A JP 2024534580 A5 JP2024534580 A5 JP 2024534580A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163261515P | 2021-09-23 | 2021-09-23 | |
| US63/261,515 | 2021-09-23 | ||
| US202263362003P | 2022-03-28 | 2022-03-28 | |
| US63/362,003 | 2022-03-28 | ||
| PCT/US2022/076747 WO2023049721A1 (en) | 2021-09-23 | 2022-09-21 | Methods of treating metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534580A JP2024534580A (ja) | 2024-09-20 |
| JP2024534580A5 true JP2024534580A5 (https=) | 2025-09-30 |
Family
ID=83902766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518431A Pending JP2024534580A (ja) | 2021-09-23 | 2022-09-21 | 代謝障害を処置する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230241024A1 (https=) |
| EP (1) | EP4404925A1 (https=) |
| JP (1) | JP2024534580A (https=) |
| KR (1) | KR20240110935A (https=) |
| AU (1) | AU2022348905A1 (https=) |
| CA (1) | CA3233074A1 (https=) |
| MX (1) | MX2024003459A (https=) |
| TW (1) | TW202312999A (https=) |
| WO (1) | WO2023049721A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009049095A1 (de) | 2009-10-01 | 2011-04-07 | Alfred Kärcher Gmbh & Co. Kg | Pumpe für ein Hochdruckreinigungsgerät |
| UA130249C2 (uk) | 2018-02-16 | 2025-12-31 | Сумітомо Фарма Америка, Інк. | Солі, кристалічні форми і способи їх отримання |
| KR20250088777A (ko) * | 2022-10-28 | 2025-06-17 | 스미토모 파마 아메리카, 인크. | 불안 및 연관된 상태를 치료하기 위한 울로타론트 |
| WO2025014889A2 (en) * | 2023-07-07 | 2025-01-16 | Procompounding, Llc | Semaglutide formulations |
| US20250262185A1 (en) * | 2024-02-16 | 2025-08-21 | Sumitomo Pharma America, Inc. | Methods of administering neuropsychiatric medications based on renal impairment |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| SG10201510665WA (en) | 2009-12-04 | 2016-01-28 | Sunovion Pharmaceuticals Inc | Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders |
| MX390141B (es) | 2017-02-16 | 2025-03-20 | Sunovion Pharmaceuticals Inc | Metodos para tratar esquizofrenia |
| UA130249C2 (uk) | 2018-02-16 | 2025-12-31 | Сумітомо Фарма Америка, Інк. | Солі, кристалічні форми і способи їх отримання |
| JP2021513972A (ja) | 2018-02-16 | 2021-06-03 | サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | 社会的機能障害の治療方法 |
| US20200179336A1 (en) | 2018-12-06 | 2020-06-11 | Sunovion Pharmaceuticals Inc. | Methods of treating neurological and psychiatric disorders |
-
2022
- 2022-09-21 AU AU2022348905A patent/AU2022348905A1/en active Pending
- 2022-09-21 EP EP22793332.2A patent/EP4404925A1/en active Pending
- 2022-09-21 JP JP2024518431A patent/JP2024534580A/ja active Pending
- 2022-09-21 MX MX2024003459A patent/MX2024003459A/es unknown
- 2022-09-21 KR KR1020247012895A patent/KR20240110935A/ko active Pending
- 2022-09-21 WO PCT/US2022/076747 patent/WO2023049721A1/en not_active Ceased
- 2022-09-21 CA CA3233074A patent/CA3233074A1/en active Pending
- 2022-09-21 US US17/933,881 patent/US20230241024A1/en not_active Abandoned
- 2022-09-22 TW TW111135909A patent/TW202312999A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534580A5 (https=) | ||
| Mazzotti et al. | Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | |
| HK1243369A1 (zh) | 用於治疗非酒精性脂肪肝病的acc抑制剂组合治疗 | |
| KR20080106455A (ko) | 대사장애의 조합치료 | |
| Usui et al. | Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients | |
| MX2011007393A (es) | Composicion y metodo para el tratamiento de la diabetes. | |
| CN117677395A (zh) | 长效glp1/胰高血糖素受体激动剂的剂量方案 | |
| CN112007023A (zh) | 黄芩素在制备防治肥胖症及其并发症药物中的用途 | |
| WO2022177742A2 (en) | Tirzepatide therapeutic methods | |
| JPWO2006011397A1 (ja) | 糖尿病の予防または治療のための薬剤 | |
| JP2025160480A (ja) | 不眠症を治療するためのレンボレキサントの使用 | |
| WO2005105109A1 (en) | Oral modified-release lozenges and their preparation method | |
| TW202000209A (zh) | 新穿心蓮內酯之組成物用於血糖調降之應用 | |
| CN109999044B (zh) | 一种含有醉茄素a的组合物及其应用 | |
| CN106727507A (zh) | 白花前胡乙素的医药用途 | |
| CN113440536B (zh) | 一种用于防治糖尿病的药物及其用途 | |
| CN114929229A (zh) | 用米立可兰治疗抗精神病药导致的体重增加的方法 | |
| CN120789063B (zh) | 一种药物组合物、制剂及其制备方法和应用 | |
| US20060166957A1 (en) | Methods of treating obesity and related disorders using tellurium selenium compounds | |
| TWI698244B (zh) | 小分子褐藻醣膠與藻褐素之組合物用於製備改善非酒精性脂肪肝之組成物的用途 | |
| CN110575447A (zh) | 一种用于防治糖尿病的药物组合物及其用途 | |
| JP2006519881A5 (https=) | ||
| JP2012503598A (ja) | 糖尿病治療のための医薬組成物 | |
| RU2834226C2 (ru) | Композиция glp-1 для лечения ожирения и регулирования веса | |
| CN120302978A (zh) | 包含胆烷衍生物和他汀类或熊去氧胆酸的药物组合 |